Cite
HARVARD Citation
Signoriello, E. et al. (2016). Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis. Multiple sclerosis. pp. 921-925. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Signoriello, E. et al. (2016). Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis. Multiple sclerosis. pp. 921-925. [Online].